Temporary Epicardial Pace Wire With Integrated Sensor for Continuous Postoperative Monitoring of Myocardial Function
Launched by CARDIACCS AS · May 10, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Echocardiography is currently the most important and most widely used tool in cardiology besides electrocardiography (ECG). It is reliable for assessing all stages of cardiovascular disease, and it is commonly used to detect heart (cardiac) wall motion dysfunction during and after open-heart surgery.
During open-heart surgery, transesophageal echocardiography (when the echocardiography sensor is introduced into the esophagus) is used to monitor cardiac wall motion at various time points during surgery. After surgery, the measurements are made at various time points by transthoracic echocar...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with heart disease requiring surgery
- • 2. Above 18 years
- • 3. Patients suitable for study participation without safety concerns based on the Investigator's evaluation of medical history and physical examination.
- • 4. The patient must be able to understand the aims and objectives of the trial, willing and able to comply with all study related procedures
- • 5. The patient must be willing and able to provide written informed consent prior to participation in the clinical investigation
- • 6. The patient agrees to abstain from enrollment in any other clinical investigation for the duration of the study
- Exclusion Criteria:
- • 1. Esophageal disease
- • 2. Atrial fibrillation
- • 3. Pregnancy
About Cardiaccs As
Cardiaccs AS is an innovative clinical trial sponsor dedicated to advancing cardiac care through the development and commercialization of cutting-edge medical technologies. With a strong focus on improving patient outcomes, Cardiaccs AS leverages a multidisciplinary team of experts in cardiology, engineering, and regulatory affairs to drive research initiatives. The company is committed to conducting rigorous clinical trials that adhere to the highest ethical standards and regulatory requirements, ensuring the efficacy and safety of its products. Through collaboration with healthcare professionals and institutions, Cardiaccs AS aims to redefine the landscape of cardiovascular medicine and enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials